Research progress of immunotherapy in locally advanced cervical cancer
10.12354/j.issn.1000-8179.2023.20231124
- VernacularTitle:免疫治疗在局部晚期宫颈癌中的研究进展
- Author:
Chunyan LIU
1
;
Wenxin LIU
Author Information
1. 天津医科大学肿瘤医院妇科肿瘤科,国家恶性肿瘤临床医学研究中心,天津市"肿瘤防治"重点实验室,天津市恶性肿瘤临床医学研究中心(天津市 300060)
- Keywords:
immunotherapy;
concurrent chemoradiotherapy;
neoadjuvant therapy;
locally adjuvant cervical cancer(LACC)
- From:
Chinese Journal of Clinical Oncology
2023;50(24):1280-1283
- CountryChina
- Language:Chinese
-
Abstract:
Cervical cancer is the most common reproductive system malignancy in women.Its primary cause is persistent infection with high-risk human papillomavirus.Traditional treatment methods include surgery,radiotherapy,and chemotherapy,but the prognosis for ad-vanced cervical cancer remains dismal.In recent years,therapeutic vaccines,immune checkpoint inhibitors,adoptive T cell therapy,and oth-er immunotherapies have been widely used in cervical cancer,notably improving patient survival.This article reviews clinical trials and re-cent advances in immunotherapy for in locally advanced cervical cancer(LACC).
